Relevant to our upcoming class investment proposal discussion, note that rumors have Johnson & Johnson (JNJ) making a bid for Swiss medical device maker Synthes. The chatter places the deal at about $20 billion.
JNJ's business model is grounded in acquisitions. The company has made more than 30 material deals in the last 15 years. However, most of JNJ purchases are on the small side; only a few have exceeded $2 billion.
Should the Sunthes purchase rumors become reality, it would be the largest acquisition in JNJ history.
position in JNJ
Showing posts with label acquisitions. Show all posts
Showing posts with label acquisitions. Show all posts
Sunday, April 17, 2011
Subscribe to:
Posts (Atom)